Use of technetium-99m macroaggregated albumin to evaluate the position and condition of totally implanted venous and arterial access devices.
Technetium-99m macroaggregated albumin is used to assess the proper location and condition of a totally implanted venous and arterial access system prior to infusion therapy. The risk of drug extravasation is thus avoided. Delivery of the chemotherapeutic agents to the intended location is assured.
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001808:Blood Vessels; D002408:Catheters, Indwelling; D006801:Humans; D012709:Serum Albumin; D013667:Technetium; D013668:Technetium Tc 99m Aggregated Albumin
D000970:Antineoplastic Agents; D012709:Serum Albumin; D013668:Technetium Tc 99m Aggregated Albumin; D013667:Technetium